Insufficient scRNA-seq data for expression of IBSP at single-cell level.
Insufficient scRNA-seq data for expression of IBSP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 7.47 | 1 / 1 |
esophagus | 14% | 1.20 | 199 / 1445 | 77% | 3.80 | 140 / 183 |
pancreas | 21% | 2.90 | 70 / 328 | 65% | 3.38 | 115 / 178 |
brain | 45% | 11.41 | 1186 / 2642 | 35% | 14.55 | 248 / 705 |
breast | 7% | 0.43 | 31 / 459 | 73% | 14.35 | 817 / 1118 |
lung | 21% | 2.09 | 119 / 578 | 52% | 3.53 | 606 / 1155 |
ovary | 2% | 0.08 | 3 / 180 | 63% | 4.24 | 273 / 430 |
bladder | 19% | 0.95 | 4 / 21 | 44% | 2.40 | 222 / 504 |
intestine | 15% | 1.48 | 148 / 966 | 46% | 3.16 | 241 / 527 |
tonsil | 0% | 0 | 0 / 0 | 51% | 3.44 | 23 / 45 |
stomach | 4% | 0.36 | 15 / 359 | 44% | 2.61 | 126 / 286 |
blood vessel | 39% | 308.39 | 522 / 1335 | 0% | 0 | 0 / 0 |
kidney | 12% | 0.82 | 11 / 89 | 26% | 1.69 | 236 / 901 |
muscle | 38% | 8.41 | 308 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 14% | 1.20 | 37 / 258 | 20% | 2.37 | 47 / 230 |
skin | 13% | 1.74 | 233 / 1809 | 21% | 1.21 | 99 / 472 |
uterus | 5% | 0.51 | 8 / 170 | 28% | 7.90 | 128 / 459 |
thymus | 7% | 0.60 | 48 / 653 | 21% | 0.83 | 129 / 605 |
liver | 2% | 0.23 | 5 / 226 | 24% | 2.59 | 98 / 406 |
heart | 17% | 2.00 | 150 / 861 | 0% | 0 | 0 / 0 |
adipose | 17% | 3.56 | 206 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.00 | 4 / 29 |
prostate | 8% | 0.56 | 20 / 245 | 5% | 0.19 | 24 / 502 |
eye | 0% | 0 | 0 / 0 | 9% | 0.42 | 7 / 80 |
peripheral blood | 7% | 0.81 | 68 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 0.11 | 6 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0007155 | Biological process | cell adhesion |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0030282 | Biological process | bone mineralization |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0031982 | Cellular component | vesicle |
GO_0016020 | Cellular component | membrane |
GO_0036094 | Molecular function | small molecule binding |
GO_0005178 | Molecular function | integrin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | IBSP |
Protein name | Integrin-binding sialoprotein (Bone sialoprotein 2) (Bone sialoprotein II) (BSP II) (Cell-binding sialoprotein) |
Synonyms | BNSP |
Description | FUNCTION: Binds tightly to hydroxyapatite . Appears to form an integral part of the mineralized matrix . Probably important to cell-matrix interaction . Promotes adhesion and migration of various cells via the alpha-V/beta-3 integrin receptor (ITGAV:ITGB3) . . |
Accessions | ENST00000226284.7 P21815 |